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Abstract Okadaic acid (OKA)-sensitive phosphatase (PP2A) 
activity may modulate nutrient-induced insulin secretion from 
pancreatic P cells [Kowluru et al., Endocrinology 137 (1996) 
2315-2323). Ceramides, a new class of lipid second messengers 
may regulate PP2A |Dobrowsky and Hannun, J. Biol. Chem. 
(1992) 267, 5048-5051], and might play a role in cytokine-
mediated apoptosis in P cells [Sjoholm, FEBS Lett. 367 (1995) 
283-286]. Therefore, we investigated the regulation of PP2A-like 
activity by ceramides in isolated p (HIT-T15 or INS-1) cells. 
Cell-permeable (C2, C6 or C18) ceramides stimulated OKA-
sensitive (but not -insensitive) phosphatase activity in a 
concentration-dependent manner (0-12.5 (iM), with maximal 
stimulation (+50-100%) at < 12.5 uM. C2-dihydroceramide (a 
biologically inactive analog of C2 ceramide) failed to augment 
PP2A-like activity. Stimulatory effects of ceramides do not 
appear to be mediated via activation of the carboxyl methylation 
of the catalytic subunit of protein phosphatase 2A, since no 
effects of ceramides (up to 25 uM) were demonstrable on this 
parameter. These data identify a ceramide-activated protein 
phosphatase as a possible locus at which ceramides might exert 
their effects on p cells leading to altered insulin secretion, and 
decreased cell viability followed by apoptotic cell demise. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Glucose-induced insulin secretion from the pancreatic P cell 
involves the generation of soluble second messengers, includ-
ing ions, cyclic nucleotides, lipid hydrolytic products of phos-
pholipases, adenine and guanine nucleotides [1,2]. More re-
cently, ceramides, a new class of lipid second messengers, 
have been implicated in cell signalling in different cell types 
[3-7]. Ceramides are formed from the hydrolysis of sphingo-
myelin by membrane-bound sphingomyelinase [3-7]. Re-
cently, localization of such an enzyme activity was reported 
in isolated rat islets, mouse islets and clonal P cells [8]. Emerg-
ing data indicate that receptor activation by cytokines (e.g. 
tumor necrosis factor [TNF] or interleukin-ip [IL-ip]) results 
in the activation of a membrane-associated sphingomyelinase 
resulting in the hydrolysis of sphingomyelin to yield ceramides 
and phosphocholine [3-7]. 
There are at least two reports of regulation by ceramides of 
P cell function. 
Sjoholm [9] reported that exposure of pancreatic P cells to 
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synthetic ceramides or purified sphingomyelinase resulted in 
marked reduction in insulin production and mitogenesis. 
These effects were mimicked by IL-ip, indicating that ceram-
ides might play a key regulatory role in cytokine-mediated 
signalling in the P cell. More recently, Major and coworkers 
[10] provided evidence to indicate that long-term exposure 
(24—96 h) of isolated P cells to C2- or C6-ceramides (but 
not C2-dihydroceramide, a biologically inactive ceramide) sig-
nificantly reduced glucose- and carbachol-induced insulin se-
cretion from these cells. Furthermore, the metabolic viability 
of these cells was also markedly attenuated following exposure 
to ceramides [10]. 
Recent evidence obtained using glioma cells and rat brain 
cells [11,12] also indicates that ceramide-mediated signalling 
involves activation of a phosphoprotein phosphatase (com-
monly referred to as the ceramide-activated protein phospha-
tase; CAPP). Based upon its cytosolic distribution, sensitivity 
to low nM concentrations of OKA, and insensitivity to diva-
lent cations, CAPP was assigned to the family of okadaic acid 
(OKA)-sensitive phosphatase (PP2A) [3]. Several recent stud-
ies, including our own [13], have provided evidence to suggest 
that PP2A may play a regulatory role in P cell function. We 
also reported [13] that the catalytic subunit of PP2A (PP2Ac) 
undergoes methylation-demethylation at its C-terminal leucine 
(Leu-309), and that ebelactone, an inhibitor of PP2Ac deme-
thylation, markedly reduced nutrient-induced insulin secretion 
from normal rat islets. Taken together, these data seem to 
suggest a key modulatory role for PP2A in insulin secretion. 
The present study was, therefore, undertaken to examine 
whether the P cell PP2A is an effector protein in the ceramide 
signalling pathway and, if so, whether the effects of ceramide 
on PP2A are mediated via the carboxyl methylation of 
PP2Ac. 
2. Materials and methods 
S-Adenosyl-L-[3H]methionine (73 Ci/mmol) and [y-32P]ATP (3000 
Ci/mmol) were obtained from NEN-DuPont (Boston, MA). Histone 
(type II-AS; calf thymus), cAMP, and purified cAMP-dependent pro-
tein kinase (rabbit muscle) were purchased from Sigma (St. Louis, 
MO). OKA was obtained from LC Laboratories (Woburn, MA) or 
Sigma or Alexis (San Diego, CA). Ceramides and dihydroceramides 
were purchased from Sigma or Calbiochem (San Diego, CA). Stock 
solutions of ceramides were prepared in ethanol and diluted accord-
ingly in the reaction buffer as indicated in the text. Appropriate di-
luents were included in the control tubes. All other reagents used were 
of highest purity available. 
2.1. Sources of fj cells and isolation of subcellular fractions 
Pancreatic islets were isolated from male Sprague-Dawley rats (300-
400 g body weight) by collagenase digestion method as previously 
described [13]. HIT cells (passage number 72) were kindly provided 
by Dr. Paul Robertson, University of Minnesota Medical School 
(Minneapolis, MN). INS-1 cells were generously provided by Dr. 
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Fig. 1. Stimulation of PP2A activity by hexanoyl ceramide: concen-
tration dependence. PP2A activity was measured in INS cell cyto-
solic fraction in the presence of increasing concentrations (0-25 uM) 
of C6-ceramide. Data are expressed as percent of control activity 
(representing 2-3 pmol of 32P released/10 min) observed in the ab-
sence of ceramide and are means ± S.E.M. of the number of deter-
minations indicated in parentheses. *P < 0.05 vs. control. 
2.3. Quantitation of protein phosphatase activity 
This was carried out by quantitating the rates of hydrolysis of 32P-
labelled histone according to the method of Sjoholm et al. [14] with 
minor modifications, as described in [13]. Briefly, the reaction mixture 
(in a total volume of 100 ul) consisted of 100 mM Tris-HCl (pH 7.4), 
2 mM DTT, 1 mM EDTA and p cell protein (typically 10-20 ug). The 
reaction was started by the addition of 32P-labelled histones (corre-
sponding to 1X105 cpm) and carried out for 10 min at 30°C. It was 
terminated by adding 100 ul of 20% trichloroacetic acid. To this, 50 ul 
BSA (10 mg/ml) was added as a carrier protein, and the mixture was 
centrifuged at 12000Xg for 5 min. 150 ul of the supernatant was 
aliquoted into scintillation vials containing 5 ml scintillant, and the 
radioactivity was determined by scintillation spectrometry. For con-
trol studies, P cell proteins were omitted from the reaction mixture, 
and the values representing non-specific hydrolysis were subtracted 
from the original values for the calculation of PP2A activity. PPase 
1 -like activity was calculated as the activity remaining in the presence 
of okadaic acid and the PP2A-like activity was calculated as the 
difference between total activity (blanks subtracted) and the PPase 
1 -like activity [14]. 
2.4. Other methods 
The protein concentration in samples was assayed by a dye-binding 
method described previously [15], using BSA as a standard. SDS-
PAGE (12% acrylamide gels) was carried out as previously described 
[13]. 
Claes Wollheim, University of Geneva (Geneva, Switzerland). Both 
HIT and INS-1 cells were cultured as described previously [13]. The 
cytosolic fraction from insulin-secreting cells was obtained by centrif-
ugation of homogenate at 105000Xg for 90 min (Ultima TL-100, 
Beckman, Palo Alto, CA) as previously described [13]. 
2.2. Carboxyl methylation of PP2Ac in cell-free preparations 
The reaction mixture (100 ul) consisted of 100 mM Tris-HCl (pH 
7.5), 1 mM EDTA, 4 mM DTT, and P cell protein (10-20 ug). The 
reaction was initiated by the addition of pHJS-adenosyl methionine 
and continued for 30 min at 37°C. Modulators were present in the 
reaction mixture where indicated in the text. The reaction was termi-
nated by the addition of SDS-PAGE sample buffer, and labelled pro-
teins were separated by SDS-PAGE and degree of methylation was 
quantitated by vapor-phase equilibration assay as we described re-
cently [13]. 
3. Results 
C6-ceramide stimulated the OKA-sensitive PP2A activity in 
INS cell cytosolic fraction in a concentration-dependent man-
ner (Fig. 1). Maximal stimulation (+100%) was demonstrable 
at 12.5 uM. Higher concentrations (25 (iM) were less stimu-
latory (Fig. 1). Other ceramides, such as acetyl (C2)- and 
stearoyl (C18)-ceramides also stimulated PP2A-like activity 
in INS cell cytosol (Fig. 2) in the following rank order: 
C2 > C6 = Cl8 > C2-dihydroceramide = control. Similar stim-
ulatory effects were also demonstrable in HIT cell and normal 
rat islet cytosolic fractions (data not shown). C2-Dihydrocer-
amide, an inactive analog of C2-ceramide [11,12], failed to 
stimulate PP2A activity (Fig. 2). These data indicate specific 
regulation of PP2A activity by biologically active ceramides. 
Fig. 2. Specificity of ceramide stimulation of PP2A activity in INS 
cell cytosol. OKA-sensitive phosphatase activity was measured in 
INS cell cytosolic fraction using [32P]histone as the substrate in the 
presence of various ceramides (12.5 uM) as indicated. Data are ex-
pressed as percent of control activity (representing 2-3 pmol of 32P 
released/10 min) observed in the absence of ceramides and are 
means ± S.E.M. of the number of individual determinations as indi-
cated in parentheses. *P < 0.05 vs. control. 
Fig. 3. Lack of effect of ceramides on OKA-insensitive phosphatase 
activity. OKA-insensitive phosphatase activity was measured in INS 
cell cytosolic fraction using [32P]histone as the substrate (see Section 
2) in the presence of various ceramides (12.5 uM) as indicated. 
Data are expressed as the percent of control activity (representing 
0.7-1.0 pmol 32P released/10 min) observed in the absence of ceram-
ides and are means ± S.E.M. of the number of individual determina-
tions as indicated in parentheses. 
A. Kowluru, S.A. MetzlFEBS Letters 418 (1997) 179-182 181 
Fig. 4. Lack of effect of ceramides on the carboxyl methylation of 
PP2Ac. Carboxyl methylation of PP2Ac was measured in the INS 
cell cytosolic fraction at 37°C for 30 min using pHJS-adenosyl me-
thionine in the presence of various ceramides (12.5 uM). For com-
parative purposes, effects of OKA (50 nM) and Mn2+ (5 mM) were 
also tested in this experiment [13]. Data are means ± S.E.M. of 3-5 
determinations in each case. These data indicate that ceramides ex-
erted no significant effects on the carboxyl methylation of PP2Ac. 
In agreement with data described by us recently, OKA [13] and 
Mn2+ [19] significantly inhibited and stimulated the carboxyl meth-
ylation of PP2Ac, respectively, thereby providing negative and posi-
tive internal controls. 
In contrast, ceramides had no effect on OKA-insensitive phos-
phatase activity (Fig. 3), suggesting that the stimulatory ef-
fects of ceramides are specific to PP2A-like activity, compat-
ible with previous reports [10,11]. 
Recently, we [13] and others [16,17] have presented evidence 
to suggest that PP2Ac undergoes an OKA-sensitive carboxyl 
methylation which is associated with an increase in its cata-
lytic activity. Therefore, we investigated whether ceramide-in-
duced increases in the catalytic activity of PP2A are due to 
their stimulatory effects on the carboxyl methylation of 
PP2Ac. None of the ceramides significantly affected the car-
boxyl methylation of PP2Ac (Fig. 4). 
4. Discussion 
Even though a growing body of experimental evidence in-
dicates key regulatory roles for ceramides in cellular function 
in several cell types, very little is known about their involve-
ment in pancreatic p cell function and metabolism. Recently, 
Sjoholm reported [9] that exposure of rat islets to ceramides 
resulted in significant reduction in insulin production and mi-
togenesis. 
These effects appeared to be superimposable to those ob-
served in the presence of IL-ip, suggesting that ceramides 
might play a role in cytokine-derived signalling in p cells. 
Major and coworkers [10] have presented evidence, in abstract 
form, that long-term (24-96 h) exposure of isolated P TC3 
cells to C2- or C6-ceramides (but not inactive dihydrocera-
mide) caused marked reduction in cell viability and attenuated 
glucose- and carbachol-induced insulin release. More recent 
studies [18] from this laboratory also suggested marked reduc-
tion in sphingomyelin content in p cells exposed to cytokines 
(e.g. TNF, IL-lp and IFN-y). These data may indicate that 
cytokine binding results in receptor activation facilitating the 
hydrolysis of sphingomyelin to ceramides. Together, findings 
of Sjoholm [9] and Major and Wolf [10,18] suggest important 
roles for ceramides in the cascade of events leading to de-
creased viability and apoptotic demise of P cells. In contrast 
to these findings, however, recent studies of Kwon et al. [8] 
failed to observe clear stimulatory effects of IL-ip or TNFa 
on sphingomyelin hydrolysis in normal rat islets, mouse islets 
and clonal RINm5F cells. These investigators concluded that 
sphingomyelin hydrolysis and the consequent generation of 
ceramides may not be necessary for IL-ip-mediated produc-
tion of nitric oxide in P cells. 
Data from the present study identify a PP2A-like effector 
protein for ceramides in the p cell, indicating that a CAPP-
like activity is localized in P cells. CAPP was first reported by 
Dobrowsky and Hannun in T9 glioma cell cytosolic fraction 
[11]. In these studies ceramides stimulated, in a concentration-
dependent fashion, the hydrolysis of [32P]histone. CAPP ef-
fects seem to be specific toward phosphoserines and phospho-
threonines, and are sensitive to OKA and insensitive to diva-
lent metals. Based upon these findings, it was suggested that 
CAPP is akin to PP2A. 
As indicated above, long-term exposure of p cells to ceram-
ides causes apoptotic cell death [10,18]. Interestingly, the pu-
tative role(s) of CAPP in mediating biological effects of ce-
ramides gained support from recent studies of Wolff et al. [7] 
indicating that OKA reversed the effects of ceramide on apop-
tosis and c-myc down-regulation. Since our findings suggest 
that PP2A is one of the target enzymes for ceramides action, it 
will be interesting to examine whether coprovision of PP2A 
inhibitors (e.g. OKA) with ceramides prevents some of the 
demonstrated deleterious effects of ceramide on isolated P 
cells [9,10,18]. 
It is noteworthy that the data described in this study and in 
our earlier studies [13,19] suggest that the carboxyl methyla-
tion of PP2Ac and the PP2A catalytic activity are dissociable 
under certain conditions. For example, OKA as well as phos-
phorylated derivatives of nucleotides or hexoses inhibited 
both the carboxyl methylation of PP2Ac and PP2A activity 
[19]. On the other hand, divalent metal ions appear to stim-
ulate the carboxyl methylation of PP2Ac without significantly 
affecting the catalytic activity of PP2A [13,19]. Interestingly, 
as shown in the current study, ceramides stimulated PP2A 
activity with no demonstrable effect on the carboxyl methyl-
ation of PP2Ac. These studies may suggest that increase in the 
carboxyl methylation of PP2Ac is not by itself sufficient or 
required to increase PP2A catalytic activity. However, it 
should be kept in mind that PP2A activity measurements 
were carried out using an (exogenous) artificial substrate 
(i.e. 32P-labelled histone); regulation of the hydrolysis by 
PP2A of endogenous islet phosphoproteins may be different 
under physiologic conditions. 
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